News

« Previous 12 Next »
Viewing Page 1 of 2 | Showing Results 1 - 10 of 13

Immunotherapy study opens for patients with triple negative breast cancer

December 15, 2017
The study will compare the safety and effectiveness of pembrolizumab plus chemotherapy, versus chemotherapy alone, to determine whether the combination improves outcomes for patients with triple negative breast cancer.

Clinical trials expand options for lung cancer patients

November 22, 2017

For people with advanced lung cancer, clinical trials open up new treatment options and offer access to promising new therapies. At Providence...

Renal cancer studies at Providence Cancer Institute

October 30, 2017

T-cell checkpoint antibodies have revolutionized immunotherapy for cancer, including renal cancer. At Providence Cancer Institute, several clinical trials of these novel approaches are now open to patients with renal cancer, including two studies comparing the effectiveness of different combinations of targeted therapies and immunotherapies.

Providence Honors Early Advocate of Immunotherapy for Lifetime of Generosity and Service

October 03, 2017

In his lifetime and through his estate, the late Robert W. Franz gave close to $40 million to Providence Portland Medical Foundation. Providence Cancer Institute has been renamed in his honor.

Phase I research at Providence Cancer Institute

September 25, 2017
Phase I studies are the foundation for advancing cancer treatment with new agents and combinations of therapies. Providence Cancer Institute is often able to offer patients first-in-human clinical trials of novel cancer therapies through our own investigator-sponsored trials, and through collaborations with industry sponsors and other early-phase institutions around the country and worldwide.

Providence Wellness Watch: Breast Cancer Screening

September 01, 2017

Learn more about breast cancer screening and the importance of mammograms, featuring Dr. Anupama Acheson from Providence Cancer Institute.

Promising one-of-a-kind clinical trial adds immunotherapy to colorectal cancer treatment protocol

September 01, 2017

A first-of-its-kind clinical study may offer new hope to patients battling rectal cancer. The Phase 2 study, newly underway at Providence Cancer...

PATINA trial studies targeted therapy for breast cancer

August 28, 2017

Patients with hormone-receptor-positive, HER2-positive metastatic breast cancer may qualify for a newly opened clinical trial at Providence Cancer...

New immunotherapy studies for people with advanced melanoma

July 24, 2017

Two new studies of investigational and FDA-approved immunotherapies for advanced melanoma are opening soon at Providence Cancer Institute.

60 Minutes Australia features Patient 71, Julie Randall, and Providence Cancer Institute

July 10, 2017

With the release of her book Patient 71, Australia native Julie Randall has given cancer patients across the globe hope for life after cancer. Her remarkable story of overcoming stage IV metastatic melanoma was featured in a segment by 60 Minutes Australia chronicling her shocking diagnosis, promise to her family and determination to become “Patient 71” in an immunotherapy clinical trial at Providence Cancer Institute.

« Previous 12 Next »
Viewing Page 1 of 2 | Showing Results 1 - 10 of 13